General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
Journal
BMC Geriatrics
Date Issued
2021
Author(s)
Jungo, Katharina Tabea
Mantelli, Sophie
Rozsnyai, Zsofia
Missiou, Aristea
Weltermann, Birgitta
Mallen, Christian
Collins, Claire
Bonfim, Daiana
Kurpas, Donata
Petrazzuoli, Ferdinando
Dumitra, Gindrovel
Thulesius, Hans
Lingner, Heidrun
Johansen, Kasper Lorenz
Wallis, Katharine
Hoffmann, Kathryn
Peremans, Lieve
Pilv, Liina
Šter, Marija Petek
Bleckwenn, Markus
Sattler, Martin
van der Ploeg, Milly
Torzsa, Péter
Kánská, Petra Bomberová
Vinker, Shlomo
Assenova, Radost
Bravo, Raquel Gomez
Viegas, Rita P A
Tsopra, Rosy
Pestic, Sanda Kreitmayer
Gintere, Sandra
Koskela, Tuomas H
Lazic, Vanja
Tkachenko, Victoria
Reeve, Emily
Luymes, Clare
Poortvliet, Rosalinde K E
Rodondi, Nicolas
Gussekloo, Jacobijn
Streit, Sven
DOI
10.1186/s12877-020-01953-6
Abstract
General practitioners (GPs) should regularly review patients' medications and, if necessary, deprescribe, as inappropriate polypharmacy may harm patients' health. However, deprescribing can be challenging for physicians. This study investigates GPs' deprescribing decisions in 31 countries.
